Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.36
Delayed Data
As of Aug 28
 -0.0287 / -7.38%
Today’s Change
0.17
Today|||52-Week Range
1.05
-42.86%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close0.39
Today’s open0.41
Day’s range0.36 - 0.42
Volume192,888
Average volume (3 months)318,547
Market cap$28.7M
Dividend yield--
Data as of 4:00pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+26.19%
Earnings growth (this year)+24.19%
Earnings growth (next 5 years)--
Revenue growth (last year)-69.69%
P/E ratioNM
Price/Sales29.66
Price/Book10.86

Competitors

 Today’s
change
Today’s
% change
EYEGEyeGate Pharmaceutic...-0.15-4.01%
PRPHProPhase Labs Inc-0.07-4.43%
JAGXJaguar Animal Health...-0.57-14.25%
ONTXOnconova Therapeutic...+0.08+5.26%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 11, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$15.2M
Net profit margin-1,441.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts

Partner Offers